Evidence map›Paper›PMID 28250965›Full record

ArticleBMJ innovations2017

Health hackathons: theatre or substance? A survey assessment of outcomes from healthcare-focused hackathons in three countries.

Kristian R Olson, Madeline Walsh, Priya Garg, Alexis Steel, Sahil Mehta, Santorino Data, Rebecca Petersen, Anthony J Guarino, Elizabeth Bailey, David R Bangsberg

Open access · hybridAbstract read
In one paragraph

Article in BMJ innovations, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Hacking systemic lupus erythematosus (SLE): outcomes of the Waterlupus hackathon.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Kristian R OlsonMassachusetts General Hospital Global Health, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Consortium for Affordable Medical Technology, Boston, Massachusetts, USA.ORCID 0000-0001-9854-6850
Madeline WalshDepartment of Political Science , Williams College , Williamstown, Massachusetts , USA.
Priya GargDepartment of Hacking Medicine , Massachusetts Institute of Technology , Cambridge, Massachusetts , USA.
Alexis SteelMassachusetts General Hospital Global Health, Boston, Massachusetts, USA; Consortium for Affordable Medical Technology, Boston, Massachusetts, USA.
Sahil MehtaLattice Innovations , New Delhi , India.
Santorino DataDepartment of Pediatrics, Mbarara University of Science and Technology, Mbarara, Uganda; Consortium for Affordable Medical Technology Uganda, Mbarara, Uganda.
Rebecca PetersenDepartment of Psychology , Azimuth Psychological , Boston, Massachusetts , USA.
Anthony J GuarinoFulbright Specialist, Fulbright Scholar Program, Boston, MA, USA.
Elizabeth BaileyMassachusetts General Hospital Global Health, Boston, Massachusetts, USA; Consortium for Affordable Medical Technology, Boston, Massachusetts, USA.
David R BangsbergOregon Health and Sciences University-Portland State University , Portland, Oregon , USA.
Massachusetts General Hospital · USAzimuth (United States) · USFulbright Association · USHarvard University · USMassachusetts Institute of Technology · USMbarara University of Science and Technology · UGPortland State University · USWilliams College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare-focused hackathons are 48-hour platforms intended to accelerate novel medical technology. However, debate exists about how much they contribute to medical technology innovation. The Consortium for Affordable Medical Technologies (CAMTech) has developed a three-pronged model to maximise their effectiveness. To gauge the success of this model, we examined follow-up outcomes.

methodsOutcomes of 12 hackathons from 2012 to 2015 in India, Uganda and the USA were measured using emailed surveys. To minimise response bias, non-responding teams were coded as having made no progress.

results331 individuals provided information on 196 of 356 projects (55.1% response rate), with no difference in responses from teams participating in different countries (Cramer's V=0.09, p=0.17). 30.3% of projects had made progress after a mean of 12.2 months. 88 (24.7%) teams had initiated pilot testing, with 42 (11.8%) piloting with care providers and 24 (6.7%) with patients. Overall, 97 teams (8.1 per hackathon) drafted business plans, 22 (1.8 per hackathon) had filed patents on their innovations and 15 (1.3 per hackathon) had formed new companies. Teams raised US$64.08 million in funding (average US$5.34 million per hackathon; median award size of $1800). In addition, 108 teams (30.3%) reported at least one member working on additional technologies with people they met at a hackathon. Individual confidence to address medical technology challenges was significantly increased after attending (t(1282)=192.77, p 0.001).

conclusionCAMTech healthcare hackathons lead to consistent output with respect to medical technology innovation, including clinical trials, business plan development, securing investment capital/funding and new company formation.

Indexed as

hackathonsinnovationslow and middle income countriesmedical devicesvalue

Identifiers

PMID28250965
PMCPMC5293858
OpenAlexW2570307322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.